UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH ), a beta integrin antagonist, in patients with solid tumours

British journal of cancer, 2006-06, Vol.94 (11), p.1621-1626

2006

Volltextzugriff (PDF)

Abstract S6-04: Patient-reported outcome (PRO) results, NRG Oncology/NSABP B-35: A clinical trial of anastrozole (A) vs tamoxifen (tam) in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.S6-S6-04

2016

Volltextzugriff (PDF)

AIDS malignancy consortium (AMC) study 061: A phase I/PK study of sunitinib (S) with highly active antiretroviral therapy (HAART) in HIV+ patients with solid tumors

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.2591-2591

2011

Volltextzugriff (PDF)

A phase I trial of pegylated liposomal anthracycline and lapatinib (L) combination in the treatment of metastatic breast cancer (MBC): First evaluation of an anthracycline and lapatinib combination in the treatment of MBC

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.1079-1079

2007

Volltextzugriff (PDF)

Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and older

Cancer, 2003-09, Vol.98 (5), p.918-925

2003

Volltextzugriff (PDF)

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) Trial After Completion of 5 Years' Adjuvant Treatment for Breast Cancer

Breast diseases, 2006-07, Vol.17 (2), p.188-188

2006

Volltextzugriff (PDF)

Phase I trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a beta integrin antagonist, in patients with solid tumours

British journal of cancer, 2006, Vol.94 (11), p.1621-1626

2006

Volltextzugriff (PDF)

Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer

Cancer chemotherapy and pharmacology, 2015-04, Vol.75 (4), p.659-670

2015

Volltextzugriff (PDF)

Matrix Metalloproteinase Inhibitor COL-3 in the Treatment of AIDS-Related Kaposi’s Sarcoma: A Phase I AIDS Malignancy Consortium Study

Journal of clinical oncology, 2002-01, Vol.20 (1), p.153-159

Cianfrocca, M.

2002

Volltextzugriff (PDF)

Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma

Oncogene, 2016-06, Vol.35 (26), p.3432-3442

2016

Volltextzugriff (PDF)

β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling

Oncogene, 2013-10, Vol.32 (42), p.5066-5077

2013

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of Lapatinib in Combination with Letrozole in Patients with Advanced Cancer

Clinical cancer research, 2008-07, Vol.14 (14), p.4484-4490

2008

Volltextzugriff (PDF)

Randomized Trial of Paclitaxel Versus Pegylated Liposomal Doxorubicin for Advanced Human Immunodeficiency Virus-Associated Kaposi Sarcoma: Evidence of Symptom Palliation From Chemotherapy

Cancer, 2010-08, Vol.116 (16), p.3969-3977

2010

Volltextzugriff (PDF)

Saliva Cortisol and Exposure to Aircraft Noise in Six European Countries

Environmental health perspectives, 2009-11, Vol.117 (11), p.1713-1717

2009

Volltextzugriff (PDF)

Annoyance due to aircraft noise has increased over the years—Results of the HYENA study

Environment international, 2009-11, Vol.35 (8), p.1169-1176

2009

Volltextzugriff (PDF)

Endothelin A receptor drives invadopodia function and cell motility through the [beta]-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma

Oncogene, 2016-06, Vol.35 (26), p.3432

2016

Volltextzugriff (PDF)

Risk factors for hypoglycemia in patients with type 2 diabetes, hospitalized in internal medicine wards: Findings from the FADOI-DIAMOND study

Diabetes research and clinical practice, 2016-05, Vol.115, p.24-30

2016

Volltextzugriff (PDF)

Primary results, NSABP B-35/NRG Oncology: A clinical trial of anastrozole vs tamoxifen in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy A randomized clinical trial

The Lancet (British edition), 2015-12, Vol.387 (10021), p.849-856

2015

Volltextzugriff (PDF)

[beta]-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced [beta]-catenin signaling

Oncogene, 2013-10, Vol.32 (42), p.5066

2013

Volltextzugriff (PDF)

Primary results, NRG Oncology/NSABP B-35: A clinical trial of anastrozole (A) versus tamoxifen (tam) in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy

Journal of clinical oncology, 2015-06, Vol.33 (18_suppl), p.LBA500-LBA500

2015

Volltextzugriff (PDF)

Primary results, NRG Oncology/NSABP B-35: A clinical trial of anastrozole (A) versus tamoxifen (tam) in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.LBA500-LBA500

2015

Volltextzugriff (PDF)

Aligning cancer quality metrics across the continuum of community-based and academic medicine using a prioritization tool

Journal of clinical oncology, 2012-12, Vol.30 (34_suppl), p.270-270

2012

Volltextzugriff (PDF)

Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus‐associated Kaposi sarcoma

Cancer, 2010-08, Vol.116 (16), p.3969-3977

2010

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Female
(14)
Humans
(14)
Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Middle Aged
(10)
Oncology
(9)
Male
(7)
Adult
(6)
Aged
(6)
Tumors
(6)
Breast Neoplasms - Drug Therapy
(5)
Biological And Medical Sciences
(4)
Breast Neoplasms - Surgery
(4)
Medical Sciences
(4)
Ovarian Cancer
(4)
Breast Neoplasms - Pathology
(3)
Carcinoma, Ductal, Breast - Drug Therapy
(3)
Carcinoma, Ductal, Breast - Surgery
(3)
Chemotherapy
(3)
Internal Medicine
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH ), a beta integrin antagonist, in patients with solid tumours

Abstract S6-04: Patient-reported outcome (PRO) results, NRG Oncology/NSABP B-35: A clinical trial of anastrozole (A) vs tamoxifen (tam) in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy

AIDS malignancy consortium (AMC) study 061: A phase I/PK study of sunitinib (S) with highly active antiretroviral therapy (HAART) in HIV+ patients with solid tumors

A phase I trial of pegylated liposomal anthracycline and lapatinib (L) combination in the treatment of metastatic breast cancer (MBC): First evaluation of an anthracycline and lapatinib combination in the treatment of MBC

Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and older

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) Trial After Completion of 5 Years' Adjuvant Treatment for Breast Cancer

Phase I trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a beta integrin antagonist, in patients with solid tumours

Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer

Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

Matrix Metalloproteinase Inhibitor COL-3 in the Treatment of AIDS-Related Kaposi’s Sarcoma: A Phase I AIDS Malignancy Consortium Study

Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma

β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling

A Phase I and Pharmacokinetic Study of Lapatinib in Combination with Letrozole in Patients with Advanced Cancer

Randomized Trial of Paclitaxel Versus Pegylated Liposomal Doxorubicin for Advanced Human Immunodeficiency Virus-Associated Kaposi Sarcoma: Evidence of Symptom Palliation From Chemotherapy

Saliva Cortisol and Exposure to Aircraft Noise in Six European Countries

Annoyance due to aircraft noise has increased over the years—Results of the HYENA study

Endothelin A receptor drives invadopodia function and cell motility through the [beta]-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma

Risk factors for hypoglycemia in patients with type 2 diabetes, hospitalized in internal medicine wards: Findings from the FADOI-DIAMOND study

Primary results, NSABP B-35/NRG Oncology: A clinical trial of anastrozole vs tamoxifen in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy A randomized clinical trial

[beta]-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced [beta]-catenin signaling

Primary results, NRG Oncology/NSABP B-35: A clinical trial of anastrozole (A) versus tamoxifen (tam) in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy

Primary results, NRG Oncology/NSABP B-35: A clinical trial of anastrozole (A) versus tamoxifen (tam) in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy

Aligning cancer quality metrics across the continuum of community-based and academic medicine using a prioritization tool

Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus‐associated Kaposi sarcoma

Suchergebnisse filtern